CXCL13 and myasthenia gravis: Accordingly,Meraouna et al. (36) reported that CXCL13expression was also increased in the thymus as well as in sera of MG patients notreceiving glucocorticoid therapy and that CXCL13 level decreased with glucocorticoidtreatment, in correlation with clinical improvement.